Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study

References

• Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000;61:276–81.
   PubMed Web of Science ®Google Scholar
• Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001;62(Suppl 3): 10–21.
   PubMed Web of Science ®Google Scholar
• Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002;36:1577–89.
   PubMed Web of Science ®Google Scholar
• Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, . Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63:357–66.
   PubMed Web of Science ®Google Scholar
• Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, . Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005;66:686–92.
   PubMed Web of Science ®Google Scholar
• Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousoño M, Calcedo A, . SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:176–94.
   PubMed Web of Science ®Google Scholar
• Zajecka JM. Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry 2000;61(Suppl 2):20–5.
   PubMed Web of Science ®Google Scholar
• DeRogatis LR. Sexual function and quality of life: endpoints and outcomes. J Gen Specif Med 2001;4:35–42.
   PubMedGoogle Scholar
• Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4: 917–29.
   PubMed Web of Science ®Google Scholar
• McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26:25–40.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th. Text revision (DSM–IV-TR); 2000.
   Google Scholar
• World Health Organization (WHO). International classification of diseases. 10th revision (ICD–10); 2007.
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology – Revised (DHEW Publ No ADM 76-338). Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch Division of Extramural Research Programs; 1976. 218–22.
   Google Scholar
• Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, . The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573–83.
   PubMed Web of Science ®Google Scholar
• Dueñas H, Tapia-Paniagua G, Vazquez-Barquero JL, Acuna A, Madrigal E, Celis A, . The integral inventory for depression (IID), a new clinimetric tool for the emotional and physically painful dimension of depression. 2nd International Congress of the World Federation of Societies of Biological Psychiatry (WFSBP); April 17–21 Poster 02-07, Santiago, Chile; 2007.
   Google Scholar
• EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199–208.
   PubMed Web of Science ®Google Scholar
• Sheehan DV. The Anxiety Disease, Charles Scribner & Sons, New York, 1983.
   Google Scholar
• Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55.
   Web of Science ®Google Scholar
• D'Agnostino RB Jr. Tutorial in biostatistics: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265–81.
   PubMed Web of Science ®Google Scholar
• Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. J Clin Psychopharmacol 2007;27:672–6.
   PubMed Web of Science ®Google Scholar
• Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004;65: 521–30.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics 2004;45: 17–28.
   PubMed Web of Science ®Google Scholar
• Muñoz RA, McBride ME, Brnabic AJ, Lopez CJ, Hetem LA, Secin R, Dueñas HJ. Major depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of life. J Affect Disord 2005;86:93–8.
   PubMed Web of Science ®Google Scholar
• Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Depress Anxiety 2008;25: E1–11.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999;19: 67–85.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999 56:201–8.
   PubMed Web of Science ®Google Scholar
• Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. J Psychiatr Res 2006;40:337–48.
   PubMed Web of Science ®Google Scholar